E
Medicenna Therapeutics Corp. MDNA.TO
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 51.06% 54.48% -72.86% -128.92% -198.13%
Total Depreciation and Amortization 725.86% 1,253.57% 807.14% 371.43% 61.11%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -161.21% -166.98% 1,332.04% 340.17% 255.25%
Change in Net Operating Assets 25.54% 67.23% -119.06% -112.15% 13.32%
Cash from Operations -13.61% 1.83% -17.64% -25.03% -8.05%
Capital Expenditure 93.39% -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 93.39% -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -85.81% -- -- 16,005.15% -12.86%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -87.59% -- 12,377.81% 40,072.41% -16.25%
Foreign Exchange rate Adjustments -138.58% 339.30% 310.54% 98.06% -30.63%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -354.92% 147.97% 155.88% 131.84% -47.79%